Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: Improved dissolution behavior and physical stability without evidence of intermolecular interactions

European Journal of Pharmaceutical Sciences

Volumn 62, Issue , 2014, Pages 57-64

  Dengale, Swapnil J ^a   Ranjan, Om Prakash ^a   Hussen, Syed Sajjad ^a   Krishna, B S M ^a   Musmade, Prashant B ^a   Gautham Shenoy, G ^a   Bhat, Krishnamurthy ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Amorphous forms; Dissolution; Indomethacin; Ritonavir; Solubility

Indexed keywords

INDOMETACIN; RITONAVIR; SOLVENT; GLASS;

ARTICLE; CALCULATION; CHEMICAL INTERACTION; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG STABILITY; EVAPORATION; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SAMPLING; SOLUBILITY; STRUCTURE ACTIVITY RELATION; X RAY POWDER DIFFRACTION; CHEMISTRY; CRYSTALLIZATION; INFRARED SPECTROSCOPY; POWDER DIFFRACTION; TRANSITION TEMPERATURE; X RAY DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DRUG STABILITY; GLASS; INDOMETHACIN; POWDER DIFFRACTION; RITONAVIR; SOLUBILITY; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TRANSITION TEMPERATURE; X-RAY DIFFRACTION;

EID: 84902345480     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2014.05.015     Document Type: Article

References (25)

1. J. Aaltonen, K.C. Gordon, C.J. Strachan, and T. Rades Perspectives in the use of spectroscopy to characterise pharmaceutical solids Int. J. Pharm. 364 2008 159 169
2. M. Allesø, N. Chieng, S. Rehder, J. Rantanen, T. Rades, and J. Aaltonen Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: amorphous naproxen-cimetidine mixtures prepared by mechanical activation J. Controlled Release 136 2009 45 53
3. D.E. Alonzo, G.G.H. Zhang, D. Zhou, Y. Gao, and L.S. Taylor Understanding the behavior of amorphous pharmaceutical systems during dissolution Pharm. Res. 27 2010 608 618
4. D.E. Alonzo, G.Z. Zhang, D. Zhou, Y. Gao, and L.S. Taylor Understanding the behavior of amorphous pharmaceutical systems during dissolution Pharm. Res. 27 2010 608 618
5. J.A. Baird, and L.S. Taylor Evaluation of amorphous solid dispersion properties using thermal analysis techniques Adv. Drug Deliv. Rev. 64 2012 396 421
6. B.A. Brahamsson, and H. Lennernas Application of the biopharmaceutic classification system now and in the future H.V. Waterbeemd, H. Lennernas, P. Artursson, Drug Bioavailability-Estimation of Solubility, Permeability, Absorption & Bioavailability 2002 Wiley-VCH Weinheim 495 531
7. N. Chieng, J. Aaltonen, D. Saville, and T. Rades Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation Eur. J. Pharm. Biopharm. 71 2009 47 54
8. L. Di, P.V. Fish, and T. Mano Bridging solubility between drug discovery and development Drug Discov. Today. 17 2012 486 495
9. E. Fakuoka, M. Makita, and S. Yamamura Glassy state of pharmaceuticals III. Thermal properties and stability of glassy pharmaceuticals and their binary glassy systems Chem. Pharm. Bull. 37 1989 1047 1050 (Pubitemid 19144144)
10. B.C. Hancock, and M. Parks What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 17 2000 397 404 (Pubitemid 30395293)
11. B.C. Hancock, and G. Zografi Characteristics and significance of the amorphous state in pharmaceutical systems J. Pharm. Sci. 86 1997 1 12
12. K. Kawakami Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs Adv. Drug Deliv. Rev. 64 2012 480 495
13. R. Laitinen, K. Lobmann, C.J. Strachan, H. Grohganz, and T. Rades Emerging trends in the stabilization of amorphous drugs Int. J. Pharm. 453 2013 65 79
14. D. Law, S. Krill, F. Schmidt, J. Fort, Y. Qiu, W. Wang, and W. Porter Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions J. Pharm. Sci. 90 2001 1015 1025
15. K. Lobmann, R. Laitinen, H. Grohganz, K.C. Gordon, C. Strachan, and T. Rades Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen Mol. Pharm. 8 2011 1919 1928
16. K. Löbmann, C. Strachan, H. Grohganz, T. Rades, O. Korhonen, and R. Laitinen Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions Eur. J. Pharm. Biopharm. 81 2012 159 169
17. P.J. Marsac, T. Li, and L.S. Taylor Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters Pharm. Res. 26 1 2009 139 151
18. Medical reviews submitted to US-FDA Centre for Drug Evaluation and Research. Application number 22-417. < http://www.accessdata.fda.gov/ drugsatfda-docs/nda/2010/022417s000-MedR.pdf > (accessed 29.06.13).
19. S. Poddar, S. Nigade, and D. singh Designing of ritonavir solid dispersion through spray drying Pharm. Lett. 3 2011 213 223
20. F. Qian, J. Huang, and M.A. Hussain Drug-polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development J. Pharm. Sci. 99 7 2010 2941 2947
21. L.S. Taylor, and G. Zografi Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions Pharm. Res. 14 1997 1691 1698 (Pubitemid 28062912)
22. T. Vasconcelos, B. Sarmento, and P. Costa Solid dispersion as strategy to improve oral bioavailability of poor water soluble drugs Drug Discov. Today. 12 2007 1068 1075 (Pubitemid 350186132)
23. S. Yamamura, M. Momose, K. Takahashi, and S. Nagatani Solid-state interaction between cimetidine and naproxen Drug Stabil. 50 1996 173 178 (Pubitemid 27035984)
24. S. Yamamura, H. Gotoh, Y. Sakamoto, and Y. Momose Physicochemical properties of amorphous precipitates of cimetidine-indomethacin binary system Eur. J. Pharm. Biopharm. 49 2000 259 265 (Pubitemid 30229875)
25. S. Yamamura, H. Gotoh, Y. Sakamoto, and Y. Momose Physicochemical properties of amorphous salt of cimetidine and diflunisal system Int. J. Pharm. 241 2002 213 221 (Pubitemid 34718023)